MedTrace Logo

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

NCT07456865 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2026-05-15

No results posted yet for this study

Summary

The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI

Conditions

  • Urge Urinary Incontinence

Interventions

DEVICE

Altaviva™ system

Programmable neurostimulation system that delivers electrical stimulation to the tibial nerve for tibial neuromodulation therapy.

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-17
Primary Completion
2032-11-30
Completion
2032-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07456865 on ClinicalTrials.gov